Effectiveness of Dry Needling Versus Cupping Therapy for Pain in Piriformis Syndrome

Piriformis Syndrome Clinical Trial

Official title:

Effectiveness of Dry Needling Versus Cupping Therapy for Pain in Piriformis Syndrome

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT06437795
• Other study ID #: MSRSW/Batch-Fall22/715
• Status: Active, not recruiting
• Phase: N/A
• Start date: November 1, 2023
• Est. completion date: September 1, 2024

Study information

• Verified date: May 2024
• Source: Superior University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to compare the effectiveness of two popular therapeutic interventions, dry needling and cupping therapy, in alleviating pain associated with Piriformis Syndrome. Piriformis Syndrome is a neuromuscular disorder caused by the compression or irritation of the sciatic nerve by the piriformis muscle, leading to buttock pain and radiating numbness.

Description:

The study will recruit participants diagnosed with Piriformis Syndrome and will randomly assign them to receive either dry needling or cupping therapy over a specific period. The primary outcome will be the reduction in pain intensity measured by standardized pain assessment tools. Secondary outcomes will include improvements in functional mobility and quality of life. By analyzing the efficacy and patient-reported outcomes of both therapies, the study aims to provide evidence-based recommendations for clinicians treating Piriformis Syndrome.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 80
• Est. completion date: September 1, 2024
• Est. primary completion date: May 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Adults aged between 18 to 65 years.
• Diagnosed with piriformis syndrome.
• Experiencing chronic pain for at least 3 months.
• Willingness to comply with the study protocol and attend all therapy sessions.

Exclusion Criteria:

• Recent surgery on the lower back or hip.
• Presence of systemic diseases affecting muscle function (e.g., multiple sclerosis, rheumatoid arthritis).
• Pregnant or breastfeeding women.
• Use of anticoagulant medication or having a bleeding disorder.
• Participating in another clinical trial simultaneously

Related Conditions & MeSH terms

• Piriformis Muscle Syndrome
• Piriformis Syndrome
• Syndrome

Intervention

Diagnostic Test:
• Dry Needling Group
Participants in this group will receive dry needling therapy. This involves inserting thin needles into trigger points in the piriformis muscle to relieve pain and muscle tension. The therapy will be administered twice a week for 4 weeks, with each session lasting approximately 30 minutes.

Other:
• Cupping Therapy Group
Participants in this group will receive cupping therapy. This involves placing cups on the skin to create suction, which is believed to improve blood flow and reduce muscle tension. The therapy will be administered twice a week for 4 weeks, with each session lasting approximately 30 minutes.

Locations

Country	Name	City	State
Pakistan	Ghurkee Hospital	Lahore	Punjab

Sponsors (1)

Lead Sponsor	Collaborator
Superior University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual Analog Scale (VAS)	Participants will rate their pain on a scale from 0 (no pain) to 10 (worst possible pain) at the beginning and end of the study.	12 Months
Primary	Oswestry Disability Index (ODI)	This tool assesses the degree of disability in performing daily activities. Quality of life improvements measured by the SF-36 Health Survey, which evaluates physical and mental health status.	12 months